Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions

Abstract α-Synucleinopathies constitute a spectrum of neurodegenerative disorders, including Parkinson’s disease (PD), Lewy body dementia (LBD), Multiple System Atrophy (MSA), and Alzheimer’s disease concurrent with LBD (AD-LBD). These disorders are unified by a pathological hallmark: aberrant misfo...

Full description

Saved in:
Bibliographic Details
Main Authors: Grace Kuo, Ramhari Kumbhar, William Blair, Valina L. Dawson, Ted M. Dawson, Xiaobo Mao
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Molecular Neurodegeneration
Subjects:
Online Access:https://doi.org/10.1186/s13024-025-00797-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585341289103360
author Grace Kuo
Ramhari Kumbhar
William Blair
Valina L. Dawson
Ted M. Dawson
Xiaobo Mao
author_facet Grace Kuo
Ramhari Kumbhar
William Blair
Valina L. Dawson
Ted M. Dawson
Xiaobo Mao
author_sort Grace Kuo
collection DOAJ
description Abstract α-Synucleinopathies constitute a spectrum of neurodegenerative disorders, including Parkinson’s disease (PD), Lewy body dementia (LBD), Multiple System Atrophy (MSA), and Alzheimer’s disease concurrent with LBD (AD-LBD). These disorders are unified by a pathological hallmark: aberrant misfolding and accumulation of α-synuclein (α-syn). This review delves into the pivotal role of α-syn, the key agent in α-synucleinopathy pathophysiology, and provides a survey of potential therapeutics that target cell-to-cell spread of pathologic α-syn. Recognizing the intricate complexity and multifactorial etiology of α-synucleinopathy, the review illuminates the potential of various membrane receptors, proteins, intercellular spreading pathways, and pathological agents for therapeutic interventions. While significant progress has been made in understanding α-synucleinopathy, the pursuit of efficacious treatments remains challenging. Several strategies involving decreasing α-syn production and aggregation, increasing α-syn degradation, lowering extracellular α-syn, and inhibiting cellular uptake of α-syn are presented. The paper underscores the necessity of meticulous and comprehensive investigations to advance our knowledge of α-synucleinopathy pathology and ultimately develop innovative therapeutic strategies for α-synucleinopathies. Graphical Abstract
format Article
id doaj-art-260211aada2b4fdd8a67d0ee9a71db10
institution Kabale University
issn 1750-1326
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Molecular Neurodegeneration
spelling doaj-art-260211aada2b4fdd8a67d0ee9a71db102025-01-26T12:52:27ZengBMCMolecular Neurodegeneration1750-13262025-01-0120112310.1186/s13024-025-00797-1Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventionsGrace Kuo0Ramhari Kumbhar1William Blair2Valina L. Dawson3Ted M. Dawson4Xiaobo Mao5Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of MedicineNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of MedicineNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of MedicineNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of MedicineNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of MedicineNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of MedicineAbstract α-Synucleinopathies constitute a spectrum of neurodegenerative disorders, including Parkinson’s disease (PD), Lewy body dementia (LBD), Multiple System Atrophy (MSA), and Alzheimer’s disease concurrent with LBD (AD-LBD). These disorders are unified by a pathological hallmark: aberrant misfolding and accumulation of α-synuclein (α-syn). This review delves into the pivotal role of α-syn, the key agent in α-synucleinopathy pathophysiology, and provides a survey of potential therapeutics that target cell-to-cell spread of pathologic α-syn. Recognizing the intricate complexity and multifactorial etiology of α-synucleinopathy, the review illuminates the potential of various membrane receptors, proteins, intercellular spreading pathways, and pathological agents for therapeutic interventions. While significant progress has been made in understanding α-synucleinopathy, the pursuit of efficacious treatments remains challenging. Several strategies involving decreasing α-syn production and aggregation, increasing α-syn degradation, lowering extracellular α-syn, and inhibiting cellular uptake of α-syn are presented. The paper underscores the necessity of meticulous and comprehensive investigations to advance our knowledge of α-synucleinopathy pathology and ultimately develop innovative therapeutic strategies for α-synucleinopathies. Graphical Abstracthttps://doi.org/10.1186/s13024-025-00797-1Prion-likeα-synucleinSpreadingReceptorTherapeutic targets
spellingShingle Grace Kuo
Ramhari Kumbhar
William Blair
Valina L. Dawson
Ted M. Dawson
Xiaobo Mao
Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
Molecular Neurodegeneration
Prion-like
α-synuclein
Spreading
Receptor
Therapeutic targets
title Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
title_full Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
title_fullStr Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
title_full_unstemmed Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
title_short Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
title_sort emerging targets of α synuclein spreading in α synucleinopathies a review of mechanistic pathways and interventions
topic Prion-like
α-synuclein
Spreading
Receptor
Therapeutic targets
url https://doi.org/10.1186/s13024-025-00797-1
work_keys_str_mv AT gracekuo emergingtargetsofasynucleinspreadinginasynucleinopathiesareviewofmechanisticpathwaysandinterventions
AT ramharikumbhar emergingtargetsofasynucleinspreadinginasynucleinopathiesareviewofmechanisticpathwaysandinterventions
AT williamblair emergingtargetsofasynucleinspreadinginasynucleinopathiesareviewofmechanisticpathwaysandinterventions
AT valinaldawson emergingtargetsofasynucleinspreadinginasynucleinopathiesareviewofmechanisticpathwaysandinterventions
AT tedmdawson emergingtargetsofasynucleinspreadinginasynucleinopathiesareviewofmechanisticpathwaysandinterventions
AT xiaobomao emergingtargetsofasynucleinspreadinginasynucleinopathiesareviewofmechanisticpathwaysandinterventions